131 related articles for article (PubMed ID: 30125581)
1. Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways.
Chen L; Li Q; Lei L; Li T
Life Sci; 2018 Sep; 209():420-429. PubMed ID: 30125581
[TBL] [Abstract][Full Text] [Related]
2. Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma.
Mao W; Yin H; Chen W; Zhao T; Wu S; Jin H; Du B; Tan Y; Zhang R; He Y
Drug Des Devel Ther; 2020; 14():2135-2147. PubMed ID: 32546976
[TBL] [Abstract][Full Text] [Related]
3. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
[TBL] [Abstract][Full Text] [Related]
4. Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
Fujishima Y; Maeda N; Matsuda K; Komura N; Hirata A; Mori T; Sekimoto R; Tsushima Y; Nishizawa H; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2014 Feb; 444(2):224-9. PubMed ID: 24462873
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
Pellieux C; Sauthier T; Aubert JF; Brunner HR; Pedrazzini T
J Hypertens; 2000 Sep; 18(9):1307-17. PubMed ID: 10994762
[TBL] [Abstract][Full Text] [Related]
6. Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.
Ma ZG; Yuan YP; Zhang X; Xu SC; Wang SS; Tang QZ
EBioMedicine; 2017 Apr; 18():179-187. PubMed ID: 28330809
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways.
Zhao QD; Viswanadhapalli S; Williams P; Shi Q; Tan C; Yi X; Bhandari B; Abboud HE
Circulation; 2015 Feb; 131(7):643-55. PubMed ID: 25589557
[TBL] [Abstract][Full Text] [Related]
8. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
9. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.
Tong Q; Qing Y; Wu Y; Hu X; Jiang L; Wu X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):166-73. PubMed ID: 25111127
[TBL] [Abstract][Full Text] [Related]
10. Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway.
Xu CN; Kong LH; Ding P; Liu Y; Fan ZG; Gao EH; Yang J; Yang LF
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165848. PubMed ID: 32473999
[TBL] [Abstract][Full Text] [Related]
11. Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation.
Chung E; Yeung F; Leinwand LA
J Appl Physiol (1985); 2012 May; 112(9):1564-75. PubMed ID: 22345431
[TBL] [Abstract][Full Text] [Related]
12. KLF15 protects against isoproterenol-induced cardiac hypertrophy via regulation of cell death and inhibition of Akt/mTOR signaling.
Gao L; Guo Y; Liu X; Shang D; Du Y
Biochem Biophys Res Commun; 2017 May; 487(1):22-27. PubMed ID: 28336438
[TBL] [Abstract][Full Text] [Related]
13. Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways.
Chen Y; Liu Z; Hu Z; Feng X; Zuo L
Bioengineered; 2022 Apr; 13(4):8323-8333. PubMed ID: 35311628
[TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling.
Bénard L; Oh JG; Cacheux M; Lee A; Nonnenmacher M; Matasic DS; Kohlbrenner E; Kho C; Pavoine C; Hajjar RJ; Hulot JS
Circulation; 2016 Apr; 133(15):1458-71; discussion 1471. PubMed ID: 26936863
[TBL] [Abstract][Full Text] [Related]
16. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
18. Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy.
Huang K; Gao L; Yang M; Wang J; Wang Z; Wang L; Wang G; Li H
Int J Biochem Cell Biol; 2017 Aug; 89():6-15. PubMed ID: 28522343
[TBL] [Abstract][Full Text] [Related]
19. Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
Liao HH; Zhang N; Feng H; Zhang N; Ma ZG; Yang Z; Yuan Y; Bian ZY; Tang QZ
Mol Cell Biochem; 2015 Nov; 409(1-2):145-54. PubMed ID: 26215454
[TBL] [Abstract][Full Text] [Related]
20. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]